Literature DB >> 8568288

Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.

A M Thackray1, H J Field.   

Abstract

The ability of famciclovir and valaciclovir to affect the establishment and maintenance of latency in mice with a cutaneous herpes simplex type 1 (HSV-1) infection was examined. Mice were treated via drinking water starting at various times between days 1 and 5 and terminating on day 10 after inoculation. Clinical signs and viral replication in the target tissues were monitored. Three to four months later, trigeminal and dorsal root ganglia were explanted from groups of 16 mice and examined for latent virus by cocultivation. The two compounds differed in their effects on the acute neural infection, and ganglia explanted from famciclovir-treated mice were markedly reduced in their ability to reactivate virus, although neither drug affected latency if treatment was delayed for several months. The difference between the compounds is likely to reflect differences in the metabolism of their respective products, penciclovir and acyclovir, in infected neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568288     DOI: 10.1093/infdis/173.2.291

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication.

Authors:  Anna Lang; James D Brien; Ilhem Messaoudi; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

2.  Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.

Authors:  R Jennings; T L Smith; F Myhren; J Phillips; M L Sandvold
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Comprehensive quantification of herpes simplex virus latency at the single-cell level.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 4.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

5.  Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.

Authors:  J M Loutsch; B Sainz; M E Marquart; X Zheng; P Kesavan; S Higaki; J M Hill; R Tal-Singer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

6.  Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells.

Authors:  J R Smith; A M Thackray; R Bujdoso
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

7.  Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.

Authors:  J Piret; J Lamontagne; A Désormeaux; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 8.  Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.

Authors:  Dene Simpson; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

9.  Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.

Authors:  J Piret; A Désormeaux; H Cormier; J Lamontagne; P Gourde; J Juhász; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

10.  Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.

Authors:  A M Thackray; H J Field
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.